FDA denies expanded approval for Alnylam RNA drug

cafead

Administrator
Staff member
  • cafead   Oct 09, 2023 at 10:42: AM
via The agency rejected Alnylam’s application for approval of its medicine patisiran in people with a rare heart condition, setting back the company’s plans.

article source
 

<